Literature DB >> 17119966

Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.

Weiguang Wang1, Howard L McLeod, James Cassidy, Elaina S R Collie-Duguid.   

Abstract

PURPOSE: Thymidylate synthase (TS) over-expression is widely accepted as a major molecular mechanism responsible for 5-fluorouracil (5-FU) and tomudex (TDX) resistance. In this study, the importance of TS in 5-FU and TDX resistance was evaluated.
METHODS: The sensitivity of TS-over-expressing 5-FU (3) and TDX (3) resistant cell lines to 5-FU and TDX was analysed. The cross-resistance between 5-FU and TDX resistant cell lines was determined. The relationship between p53 and NF-kappaB status and the sensitivity to 5-FU and TDX was evaluated.
RESULTS: Compared to relevant parental sensitive cell lines, the 5-FU resistant cell lines were highly cross-resistant to TDX (over 20,000-fold). In contrast, over-expression of TS did not significantly confer 5-FU resistance on the TDX resistant cell lines (0.8- to 1.3-fold). Thymidine (20 microM) rescue induced TDX resistance in TDX sensitive cell lines (over 10,000-fold) but only moderately influenced 5-FU sensitivity in 5-FU sensitive cell lines (1.1- to 2.4-fold). Uridine moderately protected one cancer cell line (RKO) from 5-FU-induced, but not TDX-induced, cytotoxicity. NF-kappaB transfected MCF-7 and p53 knockout HCT116 cells were resistant to 5-FU (4.4- and 2.4-fold, respectively) but not to TDX. TS protein expression in NF-kappaB transfected and p53 knockout cell lines was comparable to the relevant parental cell lines.
CONCLUSION: In some cancer cell lines, TS-independent molecular events may play a key role in 5-FU resistance. Loss of p53 function and NF-kappaB over-expression may be involved in TS-independent 5-FU chemoresistance in some cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119966     DOI: 10.1007/s00280-006-0384-5

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  18 in total

1.  Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.

Authors:  Dimitrios J Stravopodis; Panagiotis K Karkoulis; Eumorphia G Konstantakou; Sophia Melachroinou; Angeliki Thanasopoulou; Gerasimos Aravantinos; Lukas H Margaritis; Ema Anastasiadou; Gerassimos E Voutsinas
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-28       Impact factor: 4.553

2.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Authors:  Bo Song; Yuan Wang; Matthew A Titmus; Galina Botchkina; Andrea Formentini; Marko Kornmann; Jingfang Ju
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

3.  Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.

Authors:  Melanie J Jardim; Qinhong Wang; Ryohei Furumai; Timothy Wakeman; Barbara K Goodman; Xiao-Fan Wang
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

4.  Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.

Authors:  Tetsuya Minegaki; Ai Suzuki; Misato Mori; Shiori Tsuji; Satoshi Yamamoto; Airi Watanabe; Tomoyo Tsuzuki; Takaki Tsunoda; Asuka Yamamoto; Masayuki Tsujimoto; Kohshi Nishiguchi
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

5.  Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activity.

Authors:  Jamie Jennings-Gee; Timothy S Pardee; William H Gmeiner
Journal:  Exp Hematol       Date:  2012-10-17       Impact factor: 3.084

6.  Metronomic chemotherapy remodel cancer-associated fibroblasts to decrease chemoresistance of gastric cancer in nude mice.

Authors:  Chao Wang; Wenqi Xi; Jinling Jiang; Jun Ji; Yingyan Yu; Zhenggang Zhu; Jun Zhang
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

7.  Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.

Authors:  Haiyan Zhai; Jingfang Ju
Journal:  Front Genet       Date:  2011-11-03       Impact factor: 4.599

8.  APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

Authors:  Russell D Petty; Leslie M Samuel; Graeme I Murray; Graham MacDonald; Terrence O'Kelly; Malcolm Loudon; Norman Binnie; Emad Aly; Aileen McKinlay; Weiguang Wang; Fiona Gilbert; Scot Semple; Elaina S R Collie-Duguid
Journal:  BMC Cancer       Date:  2009-12-11       Impact factor: 4.430

9.  Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors.

Authors:  William H Gmeiner; Carla Lema-Tome; Denise Gibo; Jamie Jennings-Gee; Carol Milligan; Waldemar Debinski
Journal:  J Neurooncol       Date:  2013-12-18       Impact factor: 4.130

10.  Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.

Authors:  K A Kang; M J Piao; K C Kim; H K Kang; W Y Chang; I C Park; Y S Keum; Y J Surh; J W Hyun
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.